Yuyang Chang

Title: Yuyang Chang: Innovator in Liver Disease Research

Introduction

Yuyang Chang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of liver disease research through his innovative work in gene editing technology. His research focuses on the ZC3H12B gene and its implications for liver health.

Latest Patents

Yuyang Chang holds a patent for the "Use of ZC3H12B gene or protein and method for establishing animal model of liver disease." This patent describes a method for targeting the knockout of the zc3h12b gene, which leads to the establishment of an animal model exhibiting various liver lesions. The findings indicate that the absence of the ZC3H12B protein results in significant liver conditions, including hepatobiliary duct hyperplasia, hepatocyte steatosis, and fibrosis. Over time, these models develop fatty liver, local cyst necrosis, and increased lymphocyte infiltration, suggesting that ZC3H12B may serve as a treatment target and biomarker for biliary cystadenoma and related liver diseases.

Career Highlights

Yuyang Chang is affiliated with Shanghai Ocean University, where he conducts his research. His work has garnered attention for its potential applications in understanding and treating liver diseases. He has successfully established an animal model that can be utilized in further research on the pathological processes associated with biliary cystadenoma and liver cancer.

Collaborations

Yuyang Chang collaborates with Guijun Guan, contributing to advancements in their shared field of research. Their partnership enhances the scope and impact of their work in liver disease.

Conclusion

Yuyang Chang's innovative research and patent on the ZC3H12B gene highlight his significant contributions to liver disease studies. His work not only advances scientific understanding but also opens new avenues for potential treatments.